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Abstract. Previous work with the yeast Saccharomyces 
cerevisiae has demonstrated a role for a phosphatidyl- 
inositol-specific PI 3-kinase, the product of the VPS34 
gene, in the targeting of newly synthesized proteins to 
the vacuole, an organelle functionally  equivalent to 
mammalian lysosomes (Schu, P. V., K. Takegawa, M. J. 
Fry, J. H. Stack, M. D. Waterfield, and S. D. Emr. 1993. 
Science [Wash. DC]. 260:88-91).  The activity of Vps34p 
kinase is significantly  reduced by the PI 3-kinase inhibi- 
tors wortmannin, a fungal metabolite, and LY294002,  a 
quercetin analog (Stack, J. H., and S. D. Emr. 1994. J. 
BioL Chem. 269:31552-31562).  We show here that at 
concentrations which inhibit VPS34-encoded PI 
3-kinase activity, wortmannin also inhibits the process- 
ing and delivery of newly synthesized cathepsin D to 
lysosomes in mammalian cells with half-maximal inhi- 
bition of delivery occurring at 100 nM wortmannin. As 
a result of wortmannin action, newly synthesized, un- 
processed cathepsin D is secreted into the media. 
Moreover, after accumulation in the trans-Golgi net- 
work (TGN) at 20°C, cathepsin D was rapidly mis- 
sorted to the secretory pathway after addition of wort- 
mannin and shifting to 37°C. At concentrations that 
inhibited lysosomal enzyme delivery, both wortmannin 
and LY294002 caused a highly specific dilation of man- 
nose 6-phosphate receptor (M6PR)-enriched vesicles 
of the prelysosome compartment (PLC), which swelled 
to ~1 Ixm within 15 min after treatment. With increas- 
ing time, the inhibitors caused a significant yet revers- 
ible change in M6PR distribution. By 3 h of treatment, 
the swollen PLC vacuoles were essentially depleted of 
receptors and, in addition, there was a fourfold loss of 
receptors from the cell surface. However, M6PRs were 
still abundant in the TGN. These results are most con- 
sistent with the interpretation that PI 3-kinase regulates 
the trafficking  of lysosomal enzymes by interfering with 
a M6PR-dependent sorting event in the TGN. More- 
over, they provide evidence that trafficking of soluble 
hydrolases to mammalian lysosomes and yeast vacuoles 
rely on similar regulatory mechanisms. 
T 
HE targeting of newly synthesized proteins to lyso- 
somes in mammalian cells and to the functionally 
equivalent organelle in the yeast, the vacuole,  has 
been studied for a number of years. Lysosome biogenesis 
in mammalian cells has been analyzed primarily by bio- 
chemistry  and  immunocytochemistry (for  reviews  see 
Kornfeld and Mellman, 1989; Kornfeld, 1992), whereas 
the  yeast Saccharomyces  cerevisiae has  been  examined 
through a  genetic approach to generate mutants, called 
vps  for "vacuolar protein sorting", that are defective in 
various aspects of vacuole biogenesis (for reviews see Kli- 
nosky et al., 1990; Raymond et al., 1992). These different 
approaches have identified a variety of molecules that me- 
diate the specific targeting and transport of newly synthe- 
sized proteins to mammalian lysosomes and yeast vacu- 
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oles. Although the vacuole is considered to be equivalent 
to lysosomes, to date, relatively few regulatory molecules 
have been identified that are common to both pathways. 
In mammalian ceils,  newly synthesized lysosomal  en- 
zymes are specifically diverted from the secretory pathway 
by the mannose 6-phosphate (M6P) 1 recognition system 
(for reviews see Kornfeld and Mellman, 1989; Kornfeld, 
1992). Soluble lysosomal enzymes, beating M6P residues on 
their N-asparagine-linked oligosaccharides, bind to one of 
two types of M6P receptors (M6PRs)  in the trans-Golgi 
network (TGN) where receptor-enzyme complexes are se- 
lectively packaged into clathrin-coated vesicles for trans- 
port to the prelysosomal compartment (PLC), which also 
1. Abbreviations used in this paper. BFA, brefeldin A; CSF, colony stimu- 
lating factor; CSS, calf supreme supplemented; endo H, endoglycosidase 
H; M6P, mannose-6-phosphate; M6PR, mannose-6-phosphate receptors; 
MLCK, myosin light chain kinase; PDGF, platelet derived growth factor; 
PI, phosphatidylinositol; PLC, prelysosomal compartment; VSV-G, vesic- 
ular stomatitis virus glycoprotein. 
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1986; Griffiths et al., 1988; Geuze et al., 1988). In the acidic 
environment of the PLC, enzymes dissociate from their re- 
ceptors  leaving  the  receptors free  to  cycle back  to  the 
TGN for multiple rounds of transport (Brown et al., 1986; 
Geuze et al., 1988; Griffiths et al., 1988; Goda and Pfeffer, 
1988). The soluble enzymes are ultimately delivered to ly- 
sosomes  via  either maturation  of the  PLC  or  vesicular 
transport to, or fusion with, preexisting lysosomes (Mul- 
lock et al.,  1994; Roederer et al.,  1990).  Failure of newly 
synthesized lysosomal enzymes to engage the M6PR deliv- 
ery system results in their secretion (Kornfeld and Mell- 
man, 1989).  In addition to their intracellular role, M6PRs 
are also found on the cell surface, representing ,'o10% of 
the total cellular pool, where they participate in receptor- 
mediated endocytosis. Receptors move freely and rapidly 
between intracellular and cell surface pools (Braulke et 
al., 1987; Duncan and Kornfeld, 1988; Jin et al., 1989). 
Although  a  carbohydrate-mediated  vacuolar  delivery 
system has yet to be identified in yeast (Klinosky et al., 
1990), there are  several similarities  between delivery of 
soluble proteins to yeast vacuoles and mammalian  lyso- 
somes. For example, at least one soluble vacuolar enzyme, 
carboxypeptidase  Y,  appears  to  be  sorted  from  a  late 
Golgi compartment and specifically delivered to a prevac- 
uole/late  endosome-like  compartment  by  a  membrane- 
associated receptor, the product of the VPS10 gene (Gra- 
ham and Emr, 1991;  Vida et al.,  1993; Marcusson et al., 
1994). Also, delivery to the yeast vacuole requires clathrin, 
presumably to form coated vesicles  (Seeger and Payne, 
1992).  Therefore, yeast contains  a  sorting system that is 
functionally analogous to the M6P system, thus raising the 
possibility that receptor-mediated delivery of soluble pro- 
teins to lysosomes and vacuoles could be subject to similar 
mechanisms of regulation. 
A second VPS gene, VPS34, was found to encode a pro- 
tein with significant sequence similarity to the pll0 cat- 
alytic  subunit  of  mammalian  phosphatidylinositol  (PI) 
3-kinase (Herman and Emr, 1990; Hiles et al., 1992). In- 
deed, yeast cells harboring various point mutations in the 
lipid kinase  domain of Vps34p  missort soluble vacuolar 
proteins into the secretory pathway, and express greatly 
reduced levels of PI 3-kinase activity (Schu et al., 1993). In 
addition, Vps34p exists in vivo as a membrane-associated 
complex with Vpsl5p  (Stack et al.,  1993), a  soluble en- 
zyme with significant sequence homology to serine/threo- 
nine protein kinases (Herman et al.,  1991).  Interestingly, 
Vps34p  has  recently been shown  to also  exhibit  serine/ 
threonine protein kinase activity placing it in a novel class 
of enzymes capable of phosphorylating both lipid and pro- 
tein  substrates  (Stack  and  Emr,  1994).  The  only other 
known example of such an enzyme is the p110 catalytic 
subunit of mammalian PI 3-kinase (Carpenter et al., 1993; 
Dhand et al., 1994). 
The family of mammalian PI 3-kinases actually repre- 
sent mulitple biochemically distinct enzymes. The most ex- 
tensively characterized member is the pll0 catalytic sub- 
unit.  The  pll0  subunit  is  complexed  with  an  85-kD 
regulatory subunit that has SH2 domains which direct the 
binding  of  the  heterodimer  to  tyrosine-phosphorylated 
proteins  (Carpenter  et  al.,  1990;  Escobedo  et  al.,  1991; 
Morgan et al., 1990). Other members include a PI 3-kinase 
from platelets and myeloid-derived cells that is activated 
by the [3~/subunits of trimeric G protein (Stephens et al., 
1994a;  Thomason  et  al.,  1994),  and  a  PtdIns-specific 
3-kinase from bovine adrenoreticulosa cells (Stephens et 
al., 1994b). PI 3-kinases have been associated with a vari- 
ety of cellular functions including growth factor-stimulated 
mitogenesis (Cantley et al., 1991; Whitman and Cantley, 
1988), membrane ruffling (Kotani et al., 1994; Wennstrom 
et al., 1994), generation of the oxygen burst in neutrophils 
(Arcaro and Wymann, 1993; Okada et al., 1994a; Thelen et 
al.,  1994),  histamine  secretion  (Yano  et  al.,  1993),  and 
translocation  of glucose transporters  to  the  cell surface 
(Okada et al., 1994b;  Hara et al.,  1994;  Cheatham et al., 
1994). Of direct relevance to yeast Vps34p are recent stud- 
ies showing that the pl10/p85 is involved in the regulation 
of endocytic membrane trafficking events. For example, 
platelet-derived growth factor (PDGF) receptors are in- 
ternalized as a complex with pl10/p85, and mutant recep- 
tors that fail to associate with SH2 domains on the p85 tar- 
geting subunit remain at or near the cell surface (Joly et 
al., 1994). Moreover, work on the receptor for colony stim- 
ulating factor (CSF) suggests that its transport from endo- 
somes to lysosomes could also be influenced by interac- 
tions  with  the  p110/p85  complex (Carlberg  et  al.,  1991; 
Shurtleff et al., 1990). Therefore, both Vps34p in yeast and 
at least one of the PI 3-kinases in mammalian cells appear 
to function in the regulation of membrane trafficking. 
Given  these  functional  similarities,  we  investigated 
whether a PI 3-kinase plays an important role in the tar- 
geting and transport of lysosomal enzymes in mammalian 
cells. This line of inquiry is complicated by the existence of 
multiple PI 3-kinases. However, all are known to be po- 
tently inhibited by the membrane permeant reagents wort- 
mannin (Arcaro and Wymann, 1993), a fungal metabolite, 
and  LY294002,  an  analog  of the  bioflavinoid quercetin 
(Vlahos et al., 1994). For example, the well-characterized 
pll0 PI 3-kinase is exquisitely sensitive to wortmannin in 
the  low  nanomolar  range  (Arcaro  and  Wymann,  1993; 
Okada et al., 1994a; Yano et al., 1993), whereas the yeast 
PI 3-kinase (Stack and Emr, 1994), and at least one other 
mammalian PI 3-kinase is sensitive in the high nanomolar 
to low micromolar range (Stephens et al., 1994b). We re- 
port here that these PI 3-kinase inhibitors, at concentra- 
tions which inhibit the yeast Vps34p PI 3-kinase, rapidly 
cause the missorting of newly synthesized acid hydrolases 
from the lysosomal to the secretory pathway and effect the 
distribution of the M6PR. 
Materials and Methods 
Materials and Antibodies 
Wortmannin, MEM, and DMEM were obtained from Sigma Chem. Co. 
(St. Louis, MO) and LY294002 was generously provided by Chris Vlahos, 
Lilly Research Laboratories (Indianapolis, IN). Both were stored as 10- 
mM stock solutions in DMSO at -20°C. Calf Supreme Supplemented was 
obtained from GIBCO BRL (Gaithersburg, MD). Tran 35S-label was ob- 
tained from ICN (Costa Mesa, CA). FIuorescein-conjugated donkey anti- 
mouse and rhodamine-conjugated donkey anti-rabbit antibodies were ob- 
tained from Jackson Immunoresearch Labs (West Grove, PA). FAb frag- 
ments of goat anti-rabbit IgG conjugated with horseradish peroxidase was 
purchased from Biosys (Compi6gne, France). Goat anti-rabbit IgG conju- 
gated with alkaline phosphatase was from Chemicon International, Inc. 
(Temecula,  CA).  Rabbit  polyclonal  antibodies  against  TGN38  were 
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cine). Rabbit polyclonal antibodies against the cation-independent M6PR 
(Brown and Farquhar, 1987), cathepsin D (Park et al., 1991a), and mono- 
clonal antibody 10E6, recognizing a c/s-Golgi antigen (Wood et al., 1991) 
were previously characterized. 
Metabolic Labeling and Immunoprecipitation 
Briefly, CHO or NRK cells grown to near confluency on 35-ram tissue cul- 
ture dishes were incubated for 30 min in methionine-free labeling medium 
(Davidson and Balch, 1992)  followed by metabolic labeling with 100 i~Ci 
of Tran35-S  label for 30 rain. Cells were washed 3× with PBS and chased 
in methionine containing media for the indicated times in the presence or 
absence of wortmannin as described in the figure legends. To determine 
the extent of processing of intracellular forms of cathepsin D, the media 
was removed, cells were washed 2x with PBS, and scraped into 0.5 ml of 
PBS. The recovered cells were pooled with cells obtained from a second 
0.5 mi wash. Cells were pelleted and lysed in the presence of 1% Triton 
X-100 in lysis buffer (20 mM riffs, pH 8.0, 150 mM NaCI, 1 mM EDTA, 1 
mM PMSF). Cathepsin D  antibody was added and incubated for 1 h  at 
4°C. Subsequently, the lysate was supplemented with 25 ~1 of a 50% slurry 
of protein A-Sepharose beads (Pharmacia, Inc., Piscataway, N J). After an 
overnight incubation, beads were washed 2× with lysis buffer containing 
0.5% Triton X-100 and released from beads by boiling for 5 min in gel 
sample buffer as described (Davidson and Balch, 1992).  The sample was 
resolved  using  SDS-PAGE  (Laemmli,  1972),  and  the  distribution  of 
cathepsin D  between processed and unprocessed forms were quantitated 
using a  Phosphoimager (Molecular Dynamics, Inc., Sunnyvale, CA). To 
determine the recovery and processing of secreted forms of cathepsin D, 
at each time-point the media was harvested from individual tissue culture 
dishes and processed as described for intracellular forms. Radiolabeling 
and quantitation of the processing of VSV-G glycoprotein to endo H  re- 
sistant forms were determined as described (Davidson and Balch, 1993). 
Analysis of Phospholipids 
NRK cells were prepared for labeling with [32p]phosphate as follows: 80% 
confluent monolayers of cells were washed twice, phosphate-starved (in 
either Hepes-buffered DMEM  containing 44 mM NaHCO3  and 0.25% 
BSA, or phosphate-free KHB buffer [116 mM NaCl, 4.6 mM KCI, 1.16 
mM  KH2PO4,  25  mM  NaHCO3,  2.5  mM  CaC12-2H20,  1.16  mM 
MgSO4.7H20, 8 mM glucose and 0.2%  BSA]) for 45 min, and radiola- 
beled in phosphate-free DMEM or KHB buffer containing 250  ixCi of 
[32p]phosphate per dish for a total of 2.5 h in 5% CO2. Wortmannin was 
added (final concentration of 30 nM to 3 p,M) for a total time of 15-90 min 
before termination of labeling as indicated in the Results section. After 
transfer to ice, cells were washed twice with cold PBS, removed from the 
dishes by scraping into PBS, pelleted at 8,000 g for 3 min, and frozen as a 
pellet  in  liquid  N 2.  Phospholipid analysis was  performed  as  described 
(Stack et al., 1995). 
Immunocytochemistry 
The effects of the PI 3-kinase inhibitors wortmannin and LY294002 were 
examined on a variety of cells, e.g., rat clone 9 hepatocytes, NRK, CHO, 
and MDBK cells, with essentially identical results being obtained regard- 
less of cell type. For presenting the data, only the results with Clone 9 
hepatocytes will be shown. These cells were routinely maintained in mini- 
mal essential media (MEM) containing 10% Calf Supreme Supplemented 
(CSS). For all of the immunofluorescence experiments described below, 
cells were grown on coverslips for 2 d  to ~50% confluency, washed by 
quickly dunking the coverslips in a beaker containing ~50 ml of MEM 
(37°C), and then placed in another dish with MEM (but no CSS) contain- 
ing the appropriate concentration of inhibitor. The details of each experi- 
ment will be given in the Results or Figure Legends. At the end of each 
treatment, cells were fixed immediately with 3.7% formalin in PBS, pH 
7.4,  for 10-20 rain, washed 3  ×  5 in PBS, and then permeabilized with 
0.1% Triton X-100 in PBS for 5 min. Cells were further processed for sin- 
gle- or double-label immunofluorescence as described (Park et al., 1991b) 
using the following dilutions of the primary antibodies: rabbit anti-M6PR 
IgG (1:400), rabbit anti-TGN38 serum (1:200), rabbit anti-cathepsin D (1: 
400), mouse monoclonal 10E6 ascites fluid (1:400).  For doubleqabeling 
experiments, rabbit  primary antibodies were  detected  with rhodamine- 
conjugated donkey anti-rabbit IgG and mouse primary antibodies were 
detected with fluorescein-conjugated donkey anti-mouse IgG. 
For immunoperoxidase labeling and visualization by electron micros- 
copy, cells were grown for 2-3 d in 35-mm petri dishes, rinsed 2x with 
MEM, and then treated with 1 IzM wortmannin in MEM for various peri- 
ods of time at 37°C. At the end of the incubation period, cells were fixed 
with periodate-lysine-paraformaldehyde fixative and processed for immu- 
noperoxidase staining as described (Brown and Farquhar, 1989).  Rabbit 
anti-M6PR IgG was used as the primary antibody, and FAb fragments of 
goat anti-rabbit IgG conjugated with horseradish peroxidase were used as 
the second antibody. 
Acridine Orange  Accumulation 
Cells were grown on coverslips for 2 d, rinsed in MEM, and then incu- 
bated for 3 h in wortmannin (1 ~M) or NH4C1 (25 raM) in MEM at 37°C. 
Acridine orange was added from a stock solution (5 mg/ml in distilled wa- 
ter) directly to the dishes containing the coverslips to a final concentration 
of 2.5  ixg/ml.  Cells were further incubated for  10 min at 37°C, quickly 
rinsed with MEM, and placed in a 60-mm petri dish containing MEM with 
or without wortmannin or NH4CI as appropriate. Living cells were imme- 
diately  viewed  by  fluorescence  microscopy as  described  (Allison  and 
Young, 1969) and photographed using Ektachrome ASA 400 film. 
Cell Surface Binding  and Internalization of 
Anti-M6PR IgG 
To determine the relative expression of cell surface M6PRs, a cell-associ- 
ated ELISA assay was performed (Park et al., 1991b).  Clone 9 cells were 
grown in 12-well culture plates for 2 d to ~75% confluency, washed 3 x  1 
ml with MEM (37°C), and then incubated in the presence or absence of 
LY294002 (70 tJ.M) or wortmannin (1 p.M) in MEM for various periods of 
time at 37°C. All subsequent steps were done at room temperature. Cells 
were then immediately fixed in freshly prepared 3.7%  formalin in PBS, 
pH 7.4, for 30 min at room temperature, washed 3 ×  5 min with PBS, and 
incubated  with  rabbit  anti-M6PR  IgG  (50  txg/ml) for  1  h.  Ceils were 
washed 3 ×  5 min with PBS and incubated with goat anti-rabbit IgG con- 
jugated with alkaline  phosphatase (diluted  1:1,000)  for  1 h.  Cells were 
washed 3 ×  5 rnin with PBS, bound antibody was eluted with 100 mM ci- 
trate, pH 2.7, and then immediately neutralized with sodium citrate. The 
solution was clarified in a microfuge for 2 min at the highest setting, and 
the supernatant was collected.  Eluted  alkaline  phosphatase-conjugated 
antibody was assayed using 5  mM p-nitrophenyl phosphate in 100  mM 
Tris, 10 mM MgCl:, pH 9.2, for 15 min. The reaction was stopped by add- 
ing an equal volume of 5 N  NaOH, and the absorbance at 405 nm was 
measured. Cells incubated with an equal concentration of nonimmune 
IgG served as a  control  and the A40s of these samples was substracted 
from the samples incubated with immune IgG. 
Results 
Wortmannin Inhibits the Normal Processing  and 
Delivery of Newly Synthesized Lysosomal Enzymes 
To investigate the role of PI 3-kinases in the targeting of 
newly synthesized lysosomal enzymes, we  examined the 
effect of wortmannin, a  potent PI 3-kinase inhibitor, on 
cathepsin D  transport. Cathepsin D has been shown to be 
initially  synthesized  as  an  ~50-kD  unprocessed  form 
which persists as the protein passes through the secretory 
compartments  to  the  TGN  (Hasilik  and  Neufeld,  1980; 
Park et al., 1991a; Rijnboutt et al., 1992). After M6P-medi- 
ated  delivery  to  the  PLC  (prelysosome  compartment), 
cathepsin D undergoes the first of several proteolytic pro- 
cessing steps  to yield an ~44-kD  processed form. After 
reaching lysosomes, cathepsin D undergoes a much slower 
second proteolytic cleavage to yield the mature form con- 
sisting of an N30-kD polypeptide noncovalently linked to 
a  14-kD polypeptide (Gieselmann et al., 1983; Rijnboutt et 
al., 1992). As a measure of the extent of normal processing 
and trafficking, we determined the fraction of cathepsin D 
that is found in either the unprocessed form or the PLC- 
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with wortmannin. 
We first examined the normal processing and transport 
of cathepsin D  in NRK cells. Cells were pulse labeled for 
30 min and then chased for various periods of time at 37°C. 
Cathepsin  D  was  efficiently  processed  from  the  50-kD 
form to  the  44-kD  PLC-associated  form by  180  min  of 
chase (Fig. 1 A). However, addition of 1 ixM wortmannin 
to cells during the pulse chase resulted  in a  dramatic de- 
crease  in  the  processing  of the  50-kD  form  and  its  loss 
from the  cells.  After a  180-min chase  in the presence  of 
wortmannin,  <10%  of the initial  50 kD form was recov- 
ered in the cell extracts (Fig. 1 A). 
To account for the loss of cathepsin D, cells were treated 
with  increasing  concentrations  of wortmannin,  pulse  la- 
beled for 30 min, chased for 4 h, and then cathepsin D  was 
immunoprecipitated  from  both  cell  extracts  and  media 
samples. In the absence of wortmannin, ~90% of all newly 
synthesized cathepsin D  was found to be in the cell-associ- 
ated, processed form (Fig. 1 B). However, inclusion of in- 
creasing  concentrations  of wortmannin  during  the  chase 
period resulted in a progressively smaller fraction of pro- 
cessed cathepsin D  appearing in cells (Fig. 1 B, open bars) 
with  unprocessed  cathepsin  D  now  found  to  be  nearly 
quantitatively  secreted  (Fig.  1 B, closed bars).  The effect 
of wortmannin  was  observed  even  as  low  as  30-40  nM 
(data not shown). However, at 100 nM wortmannin, a sig- 
nificant amount (40%  of the total) of cathepsin D  was di- 
verted to the secretory pathway indicating that half-maxi- 
mal inhibition of sorting occurred at ,'~100 nM wortmannin. 
Maximal  inhibition  of cathepsin D  processing and diver- 
sion to the extracellular media occurred in the presence of 
1-3  /xM wortmannin,  concentrations  which were  used  in 
subsequent experiments. 
To confirm whether the observed defects in cathepsin D 
sorting correlated with a defect in PI-3 kinase activity, we 
measured  cellular  levels  of Ptdlns  3-P  after  addition  of 
varying concentrations of wortmannin. NRK cells were la- 
beled to isotopic steady state with [32p]phosphate and then 
incubated  with  various  doses  and for varying times  with 
wortmannin.  Cellular  lipids  were  extracted,  deacylated, 
and  then  fractionated  using  anion  exchange  HPLC.  We 
found that  doses  of wortmannin  (nM  to  3  IxM)  that  re- 
suited in a defect in cathepsin D  sorting, also resulted in a 
rapid decrease in cellular levels of Ptdlns 3-P. Treatment 
with  wortmannin  for as  little  as  15  min  led  to  a  greater 
than threefold (70%) reduction in the level of Ptdlns 3-P. 
This  rapid loss of PtdIns 3-P presumably corresponds  to 
the rapid inactivation of PI 3-kinase activity in these cells. 
These  observations  are  very  consistent  with  those  ob- 
tained by Stephens et al. (1994b) on a different cell type. 
Figure 1.  The  PI 3-kinase  inhibitor,  wortmannin,  inhibits  the 
processing of newly  synthesized  cathepsin  D.  (A)  NRK  cells 
were pulse labeled for 30 rain with [35]methionine, washed, and 
chased for various periods of time (all at 37°C) as indicated on 
the graph and above the gel lanes. At these time points, cathep- 
sin D  was immunoprecipitated from cell extracts, separated by 
SDS-PAGE, and analyzed by Phosphoimager. (-) Processing in 
the absence of wortmannin shows nearly complete conversion of 
the higher molecular weight 50-kD form to the 44-kD, PLC-asso- 
ciated form by 180 min of chase.  (+) In the presence of 1 ~M 
wortmannin, very little 50-kD form is processed and most of it is 
lost from the cell extracts. The graph shows the amount of the 50- 
kD form that was processed to the 44-kD form, and therefore the 
amount that reached the late endosome/PLC in untreated ceils. 
(B) Wortmannin diverts newly synthesized cathepsin D from the 
lysosomal to the secretory pathway. NRK ceils  were incubated 
with  the  indicated  concentrations  of wortmannin  for  15  min, 
pulse labeled for 30 rain with [3S]methionine, washed, and chased 
for 4 h at 37°C in the presence of cold methionine (in the continu- 
ous presence of wortmannin as appropriate).  Cathepsin D  was 
immunoprecipitated  from  cell  lysates  (open  bars) or  media 
samples (closed bars) and the amount of unprocessed (50 kD im- 
mature)  and  processed  (44  kD  PLC-associated)  forms  were 
determined using SDS-PAGE and Phosphoimager analysis as de- 
scribed  in Materials  and  Methods.  With  increasing  concentra- 
tions  of wortmannin,  the  recovery of intracellular,  processed 
forms of cathepsin D was markedly inhibited (open boxes). Loss 
of intracellular  forms was strongly correlated with the appear- 
ance  of unprocessed  cathepsin  D  in  the  media  (closed bars). 
(Inset) Wortmannin (3 p~M) had no effect on the processing of 
VSV-G to endo H resistant forms. Virus infection, radiolabeling, 
and quantitation of the processing of VSV-G was determined as 
described (Davidson and Balch, 1993). 
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common to both the constitutive secretory and lysosomal 
pathways, we examined the effect of wortmannin on the 
transport of vesicular stomatitis virus glycoprotein (VSV-G), 
a type i  membrane protein which is transported to the cell 
surface in  a  fashion identical  to plasma  membrane pro- 
teins. As shown in Fig. 1 B (inset), concentrations up to 3 
I~M wortmannin had no detectable effect on the process- 
ing of VSV-G to the endoglycosidase H (endo H) resistant 
complex form indicative of normal transport through the 
Golgi stack. In addition, there was no effect on the deliv- 
ery of VSV-G to the cell surface as detected by indirect 
immunofluorescence (data not shown). The combined re- 
suits  suggest  that  wortmannin  is  specifically affecting  a 
step related to the sorting of cathepsin D from the TGN or 
delivery to the PLC. 
Wortmannin Rapidly Diverts Newly Synthesized 
Cathepsin D to the Constitutive Secretory Pathway 
To account for the fate of the various forms of cathepsin D 
in the presence or absence of wortmannin, a time course of 
processing was more closely examined in pulse-chase ex- 
periments. In these experiments, cells were pulse labeled 
with  [35S]methionine for 30 min and  then  chased in  the 
continuous presence of wortmannin for various periods of 
time.  In the  absence of wortmannin, the majority of ca- 
thepsin D  remained in the intracellular pool as the 44-kD 
PLC form by 6 h of chase (Fig. 2). In the presence of wort- 
mannin, ~80%  of the cathepsin D  was secreted into the 
media, as the 50-kD unprocessed form by 3 h. The cathep- 
sin D  remaining in cells at this time point was exclusively 
recovered in the unprocessed form suggesting a potent de- 
fect in the delivery of wortmannin to the PLC. 
Lysosomal enzymes are sorted from the secretory path- 
way in the TGN for delivery to PLC/endosomal compart- 
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Figure 2.  Time course of cathepsin D processing and fate in the 
presence  or absence  of wortmannin.  Cells were  pulse  labeled 
with [35]methionine for 30 min, washed, and chased in the pres- 
ence of cold methionine and 3 p~M wortmannin for the indicated 
time. Cathepsin D was immunoprecipitated  from either cell ex- 
tracts or media, and the amount of processed  and unprocessed 
cathepsin D determined as described in Materials and Methods. 
ments (Kornfeld and Mellman,  1989).  To more precisely 
determine the location of the wortmannin-induced diver- 
sion of cathepsin D  from the lysosomal to the secretory 
pathway, cells were pulse labeled for 30 min and chased 
for 3 h at 20°C to accumulate newly synthesized enzyme in 
the TGN (Griffiths and Simons, 1986). Subsequently, ceils 
were incubated for 15 min at 20°C in the presence of wort- 
mannin,  to  equilibrate  the  various  trafficking  pathways 
with the drug, and then shifted to 37°C to resume transport 
(Fig. 3). Before shifting cells to 37°C, 80-90% of the cathep- 
sin D was found in cells in the unprocessed form indicating 
that it had, for the most part, not passed beyond the TGN 
(Fig. 3 A). After shifting to 37°C in the absence of wort- 
mannin, nearly all of the cathepsin D remained in the cells 
and by 3 h  of chase  >60%  was processed to the 44-kD 
PLC/lysosomal form, a value equivalent to that observed 
in control cells in this experiment which were chased for 4 h 
at 37°C in the absence of wortmannin and the 20°C block 
(65% processed to the 44-kD form). In contrast, following 
shift of cells from 20°C to 37°C in the presence of wort- 
mannin,  cathepsin  D  appeared  in  the  extracellular  me- 
dium nearly quantitatively without the 1-h lag period ob- 
served for transport from the  ER  (Fig.  2),  reflecting its 
efficient accumulation in the TGN at 20°C.  Moreover, it 
was all secreted in the unprocessed form. None of the re- 
sidual  cell-associated cathepsin  D  was  detectable  in  the 
processed forms over the background level observed be- 
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Figure 3.  Targeting and processing of newly synthesized cathep- 
sin D from the TGN to the PLC is inhibited by wortmannin. (A) 
Cells were labeled for 30 min with [35]methionine and chased for 
3 h at 20°C to accumulate unprocessed cathepsin D in the TGN 
(Griffiths and Simon, 1986). Wortmannin (3 ~M final concentra- 
tion) was added where indicated for 15 min at 20°C. Cells were 
then shifted to 37°C for the indicated time. Cathepsin D was im- 
munoprecipitated from cell extracts or media, and the amount of 
processed and unprocessed forms determined as described in Ma- 
terials and Methods. (B) Staurosporine does not affect the sort- 
ing and processing of cathepsin D. After a 3-h accumulation of 
cathepsin D at 20°C in the TGN, cells were incubated in the pres- 
ence of staurosporine (10 I~M) for 15 min at 20°C. Cells were then 
shifted to 37°C and the distribution of cathepsin D in the cells and 
media determined after a 4-h chase at 37°C as described in Mate- 
rials and Methods. 
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that wortmannin acts rapidly and virtually quantitatively, a 
result which is most consistent with a site of action at the 
TGN. 
To confirm the specificity of wortmannin on lysosomal 
enzyme targeting, we examined the effects of staurospo- 
fine, a general inhibitor of protein kinases, including myo- 
sin light chain kinase (MLCK) (Watson et al., 1988) which 
is a potential target of wortmannin at the concentrations 
being used in our studies. As shown in Fig. 3 B, the addi- 
tion of 10 IzM staurosporine 15 min before shift from 20°C 
to 37°C had no effect on the processing of cathepsin D  to 
the PLC associated 44-kD form, nor resulted in the diver- 
sion of cathepsin D  to the secretory pathway. This result 
indicates that MLCK or a broad spectrum of other protein 
kinases (sensitive to staurosporine) are not responsible for 
the observed effects of wortmannin on lysosomal enzyme 
targeting. 
Effect of PI 3-Kinase Inhibitors  on the M6PR and Its 
IntraceUular Compartments 
One explanation for the effect of wortmannin on the tar- 
geting of lysosomal enzymes is that it causes a defect in the 
M6PR transport cycle. Typically, M6PRs are found by im- 
munofluorescence microscopy to be localized in small ve- 
sicular and tubular structures  in the region  of the  Golgi 
complex near the nucleus (Fig. 4, 0 ~M), corresponding to 
the  TGN  and  the  PLC/late  endosome  compartments. 
However, addition of wortmannin for just 15 min at con- 
centrations  which  inhibited  cathepsin  D  processing  and 
delivery resulted in the formation of large M6PR-stained 
vacuoles (Fig. 4, 0.1,  1.0,  10 p,M). After a  15-min incuba- 
tion, swollen vacuoles were just detectable in 0.1 ixM wort- 
mannin, and they reached maximal diameters in 5-10 ixM 
of the inhibitor. Incubation of cells with 50-100 nM wort- 
mannin  also  resulted  in  vacuole  formation,  but  over  a 
longer period of time (data not shown). The Golgi com- 
plex, as shown by staining with the cis-Golgi specific mono- 
clonal  antibody,  10E6,  was  not  affected by wortmannin 
over this concentration range (Fig. 4). 
A  more extended time course of treatment with 1 txM 
wortmannin revealed a  striking phenotype  of the  drug's 
effect. Dilated  M6PR-stained  vacuoles were first detect- 
able even after only 5 min of treatment (data not shown), 
and by 15 min, the vacuoles had reached maximum size 
(Fig. 5, 15 min). Notably, there was a high correlation be- 
tween the M6PR-stained vacuoles and the vacuoles visual- 
ized by phase contrast microscopy (Fig. 5), as seldom were 
phase lucent vacuoles seen that did not also stain for the 
receptor after 15  min of treatment.  Gradually, however, 
the large phase lucent vacuoles stained less intensely for 
the receptor such that by 3 h  of treatment, M6PRs were 
not  detectable  in  the  vacuoles  by  immunofluorescence 
(Fig. 5, 3 h). Instead, M6PRs were found primarily in the 
juxtanuclear Golgi region, an area adjacent to but essen- 
tially lacking the large vacuoles (Fig. 5, 3 h). These results 
suggest that in the presence of wortmannin, M6PRs cycle 
out of the swollen PLC/late endosome vacuoles and accu- 
mulate  in  a  compartmentally distinct  structure,  perhaps 
the TGN. 
To obtain independent evidence for a role of PI 3-kinase 
in mammalian lysosomal enzyme targeting, we examined 
if the bioflavinoid quercetin analog, LY294002, which has 
recently been shown to be a highly selective and reversible 
inhibitor of PI 3-kinase activity (Vlahos et al., 1994), had 
an identical effect on the M6PR. We found that treatment 
of cells with LY294002 for 15 min also caused the specific 
dilation of M6PR-stained vacuoles (Fig. 6 B). In addition, 
washing cells free of the drug for 1 h allowed the vacuoles 
to  revert  to  control  morphology.  Likewise,  when  cells 
were treated with LY294002 for 3 h, and then washed free 
of the drug, M6PRs resumed their normal distribution in 
the TGN and vesicles of the PLC (data not shown). Simi- 
lar recovery experiments were tried with wortmannin but 
with inconclusive results. In fact, recent studies report con- 
flicting results concerning whether or not wortmannin is 
a  reversible inhibitor  (Clarke  et al.,  1994;  Thelen  et al., 
1994;  Woscholshi et al., 1994).  In all other aspects so far 
tested,  LY294002 was identical to wortmannin except that 
LY294002  was  effective at higher  concentrations  (50-70 
txM), consistent with the relative potencies of these inhibi- 
tors on PI 3-kinase activities (Stephens et al., 1994b;  Stack 
and Emr, 1994). 
The wortmannin- and LY294002-induced PLC vacuoles 
resembled  those  produced  after neutralization  of acidic 
compartments by the weak bases chloroquine and NH4C1 
(Brown et al., 1984,  1986), treatments which also result in 
the secretion of lysosomal enzymes (Gonzalez-Noriega et 
al., 1980).  To determine if the PI 3-kinase inhibitors were 
acting via a similar "weak base" effect on the PLC, living 
cells were incubated  with the vital fluorescent dye, acri- 
dine orange, which accumulates in acidic organelles: at low 
concentrations  acridine  orange  fluoresces green;  at  high 
concentrations after accumulation in acidic compartments 
it changes to orange-red fluorescence (Allison and Young, 
1969).  In control cells, acridine orange accumulated in nu- 
merous small vesicles corresponding to the PLC, other en- 
dosomes, and lysosomes which  showed  a  bright  orange- 
red  fluorescence  (Fig.  7 A).  In cells  treated  with  1  txM 
wortmannin for 3 h, the typical large PLC vacuoles formed 
in which  acridine orange also accumulated to produce  a 
bright orange-red fluorescence (Fig. 7 B).  Similar results 
were  obtained  with  LY294002-treated  cells  (data  not 
shown). In contrast, when cells were treated with the weak 
base NHnCI for 3 h  to neutralize the intralumenal pH of 
acidic  compartments,  numerous  vacuoles  were  formed, 
however these were unstained by acridine orange (Fig. 7 
C).  In addition,  acridine  orange staining was completely 
lost from the wortmannin-induced vacuoles by subsequent 
addition of NH4C1 (data not shown). These results suggest 
that wortmannin and LY294002 do not significantly alter 
the pH of the PLC vacuoles. 
The  above results  show  that  after 3  h  of wortmannin 
treatment, M6PRs are substantially depleted from the di- 
lated vacuoles but are still found in the juxtanuclear Golgi 
region suggesting that receptors may have returned to the 
TGN. To confirm this, cells were first treated with wort- 
mannin for 3  h  and then  subsequently with brefeldin  A 
(BFA),  a  fungal  metabolite  which  has  previously  been 
shown to induce the formation of membrane tubules from 
the TGN but not PLC/late endosomes (Tooze and Holl- 
ingshead,  1992;  Wood  et  al.,  1991;  Wood  and  Brown, 
1992).  Just as in cells treated with BFA alone (Fig. 8 B), in 
The Journal of Cell Biology, Volume 130, 1995  786 Figure 4.  Effect of wortmannin on the distribution of M6PRs. Cells were incubated for 15 min at 37°C with the concentrations of wort- 
mannin indicated on the left hand micrographs. Cells were fixed and stained by double-label immunofluorescence using polyclonal anti- 
M6PR and monoclonal 10E6 anti-Golgi antibodies. The left hand column shows the M6PR staining and the corresponding 10E6 local- 
izations are on the right. 
wortmannin-pretreated cells,  BFA induced the formation 
of long M6PR-stained  tubules  from the juxtanuclear re- 
gion, thus showing that receptors are located in the TGN 
even after 3 h of wortmannin treatment (Fig. 8 C). 
To  confirm these  immunofluorescence results,  and  to 
more  precisely  localize  M6PRs  after  wortmannin  treat- 
ment, cells were also processed for immunoperoxidase lo- 
calization by electron microscopy. In control cells, M6PRs 
are found in tubular elements of the TGN, clathrin-coated 
buds and vesicles, and in larger vesicles (0.2-0.4 p~m in di- 
ameter)  of the  PLC (Fig.  9 A).  After treatment  of cells 
with 1 IxM wortmannin for just 15 min, few of the normally 
sized, M6PR-enriched PLC vesicles, typically found near 
the  Golgi  region,  were  observed.  Instead,  large  dilated 
vacuoles  that  stained  with  anti:M6PR  antibodies  were 
found  in  the  central  regions  of the  cytoplasm near  the 
Brown et al. PI 3-Kinase and Lysosomal Enzyme Delivery  787 Figure 5.  Time course of wortmannin-induced dilation of M6PR-positive vacuoles. Cells were incubated with i  txM wortmannin at 37°C 
for the times indicated on the micrographs, fixed, and stained with anti-M6PR antibodies. Left hand column shows the M6PR staining 
and on the right are the corresponding phase contrast micrographs for each time point. Between 15 min and I h of treatment, there is a 
one-to-one correspondence between the M6PR-stained vacuoles and those seen by phase contrast microscopy. In the 15 min and 1 h mi- 
crographs, the plane of focus was centered on the vacuoles, and therefore, the juxtanuclear, Golgi signal was obscured (see Fig. 1, 1.0 for 
vacuole and Golgi region staining). By 3 h of treatment, however, the phase lucent vacuoles are still present but are no longer brightly 
stained. Instead, staining was primarily in juxtanuclear tubules and vesicles. 
Golgi complex (Fig. 9 B). These M6PR-enriched vacuoles 
reached diameters of ~1  I~m. In contrast to this distribu- 
tion, after 3 h of wortmannin treatment, the large vacuoles 
were  still present,  however,  they  stained  much  less  in- 
r tensely for M6PRs (Fig. 9 C). M6PRs were, however, eas- 
ily detected in the TGN throughout the period in which re- 
ceptors became  depleted from the large vacuoles  (Fig. 9 
C). Similar results were obtained with LY294002. 
The above results strongly suggest that the dilated vacu- 
oles produced by both wortmannin and LY294002,  which 
The Journal  of Cell Biology,  Volume 130, 1995  788 Figure 6.  The PI 3-kinase inhibitor,  LY294002, induces the re- 
versible formation  of M6PR-enriched  vacuoles. (A) Cells were 
incubated  with 70 ~M LY294002 for 15 min at 37°C and then 
fixed  with  formalin  or  (B)  washed  with  MEM  (but  without 
LY294002), and incubated in MEM plus 10% CSS for i h at 37°C. 
initially stained brightly for the M6PR but much less so by 
3 h of treatment, are derived from the PLC. However, it is 
possible  that other compartments contribute as well.  To 
determine if the vacuoles were derived from elements of 
the TGN, cells were treated with wortmannin for 15 min 
and then fixed and stained  by immunofluorescence with 
antibodies  against  TGN38.  Wortmannin  was  found  to 
have no effect on TGN38 staining (Fig. 10, TGN38). Like- 
wise,  the  lysosomes in  wortmannin-treated  cells,  as  re- 
vealed by staining with anti-cathepsin D  antibodies (Fig. 
10, CD), were not swollen and looked identical to those in 
normal cells (Wood and Brown, 1992). 
To determine if, indeed, endocytic material could be de- 
livered to the  LY294002-induced vacuoles, we examined 
the endocytosis of antibodies bound to cell surface M6PRs. 
Cells were incubated with or without LY294002 for 3 h, 
and  then  subsequently  in  the  continuous  presence  of 
LY294002 with  anti-M6PR IgG, which binds to cell sur- 
face receptors, for 30 min to allow the endocytic delivery 
of receptor-bound antibodies  to the  PLC/late endosome 
compartment.  Internalized  antibodies  were  detected  in 
fixed and permeabilized cells  with rhodamine-conjugated 
anti-rabbit  IgG  antibodies.  In  untreated  cells,  surface 
bound anti-M6PR IgG was delivered after 30 min of up- 
take to a juxtanuclear cluster of vesicles, consistent with 
delivery to the PLC (Fig.  11 A). In cells pretreated with 
LY294002 for 3 h,  anti-M6PR IgG was also internalized 
but was instead  found in  a  juxtanuclear  cluster  of large 
vacuoles (Fig.  11 B). Identical labeling of dilated vacuoles 
was obtained when cells were pretreated with LY294002 
for  only  15  min  before  uptake  of  antibodies  (data  not 
shown).  Endocytosis  of  anti-M6PR  antibodies  was  pri- 
Figure 7.  Wortmannin does not significantly affect the accumula- 
tion of the pH-sensitive dye, acridine orange, into the lumen of 
the PLC vacuoles. (A) Control cells showing small, bright orange- 
red  vesicles corresponding  to acidic organelles. (B) Cells incu- 
bated  with wortmannin  (1  p~M for 3 h) before  incubation with 
acridine orange produce swollen PLC vacuoles (arrows) that still 
fluoresce a bright  orange-red.  (C) Cells incubated  with NHaC1 
(25 mM for 3 h)  also produced  swollen vacuoles (arrows) but 
these do not accumulate acridine orange. 
marily due  to receptor-bound antibodies,  and  not fluid- 
phase  uptake,  because incubation of either untreated  or 
treated  cells  with  an  equivalent  concentration of preim- 
mune IgG did not result in a detectable intracellular signal 
(data not shown). These results show that the LY294002- 
induced vacuoles are derived from the PLC/late endoso- 
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located in the TGN. Cells were treated as indicated  below and 
then stained  by immunofluorescence  for the  M6PR.  (A)  Cells 
treated with BFA (10 ixg/ml) for 5 min at 37°C. (B) Cells treated 
with wortmannin (1 IxM) for 3 h at 37°C. The large swollen vacu- 
oles, which no longer stain intensely for the M6PR can be seen as 
"ghosts" in the cytoplasm. (C) Cells treated with wortmannin (1 
IxM) for 3 h and then with BFA (10 ~g/ml) for 5 rain at 37°C in 
the continuous presence of wortmannin. 
mal vesicles. Moreover, they demonstrate that whether or 
not  intracellular  M6PRs  are  present  in  the  dilated  PLC 
vacuoles  in  normal  amounts  (i.e.,  15  min  vs  3  h  of 
LY294002  treatment;  see  Fig.  5),  receptors  originating 
from the  cell  surface  could  nevertheless  be  internalized 
and delivered to the PLC/late endosomal compartment. 
Although  antibodies  that  were  bound  to  cell  surface 
M6PRs could be endocytosed, we noticed that the inten- 
sity of the intracellular  signal was less in cells pretreated 
with LY294002 for 3 h  than in untreated cells. This result 
could be due to a decrease in the number of cell surface re- 
ceptors, the rate of internalization,  or both. Using a  cell- 
associated ELISA assay, we found that treatment of cells 
with 70 txM LY294002 for ~2.5 h leads to a fourfold loss of 
surface receptors (Fig.  12).  Similar results were obtained 
using  wortmannin  (data  not  shown).  After  removal  of 
LY294002 for 2 h, surface receptors returned to N70% of 
the pretreated values. These results suggest that as M6PRs 
are endocytosed at the  cell surface, they are not replen- 
ished by intracellular stores. 
Discussion 
We find that the potent PI 3-kinase inhibitor, wortmannin, 
substantially  inhibits  the  processing  and  intracellular  re- 
tention of newly synthesized cathepsin D, and therefore, 
its specific delivery to lysosomes. Half-maximal inhibition 
of cathepsin D  sorting occurred at ~100 nM wortmannin 
and correlated with a threefold decrease in cellular levels 
of PtdIns 3-P. The effect of wortmannin  on cathepsin D 
trafficking was shown to involve a step specific to the lyso- 
somal pathway and not to some common step early in the 
constitutive secretory pathway because the processing and 
transport of newly synthesized VSV-G was unaffected by 
wortmannin.  Moreover,  later  steps  of  the  constitutive 
secretory pathway were likewise  unaffected because:  (a) 
VSV-G efficiently reached the cell surface; and, (b) cathep- 
sin D  was not retained within cells but was constitutively 
secreted  from cells.  Thus,  wortmannin  completely abol- 
ished sorting of cathepsin D  from the secretory pathway 
by affecting some transport step either at the level of the 
TGN or the delivery site in the PLC, but it had no observ- 
able effect on transport from the TGN to the cell surface. 
These results strongly suggest that proper trafficking of 
acid hydrolases to lysosomes in mammalian cells requires 
the  activity of a  PI 3-kinase.  The  impetus for this  work 
came from previous studies showing that the targeting and 
delivery of newly synthesized proteins to the yeast vacuole 
depend  on  the  product  of  the  VPS34  gene,  a  protein 
known to have significant homology to the pll0 catalytic 
subunit  of  mammalian  PI  3-kinase  (Herman  and  Emr, 
1990; Hiles et al., 1992)  and which has been directly dem- 
onstrated to have PI 3-kinase activity (Schu et al., 1993).  In 
addition, Stack and Emr (1994) have recently shown that 
Vps34p enzymatic activity is sensitive to  the  PI 3-kinase 
inhibitors,  wortmannin,  and  LY294002.  Finally,  the  idea 
that  wortmannin  inhibits  lysosomal  enzyme  sorting  in 
mammalian cells is consistent with studies in yeast demon- 
strating  that  soluble  vacuolar  hydrolases  appear  to  be 
sorted in the late Golgi for delivery to a  late endosome- 
like  compartment  (Vida  et  al.,  1993;  Graham and  Emr, 
1991).  Fractionation  studies  further indicate  that Vps34p 
functions  in  a  late  Golgi compartment  (Stack  and  Emr, 
1993).  Therefore,  our  separate  studies  provide evidence 
that  a  common PI 3-kinase-mediated regulatory mecha- 
nism is used for the specific targeting and transport of pro- 
teins to both mammalian lysosomes and yeast vacuoles. 
One possible complication in our studies  is that  at the 
concentrations needed  to induce  missorting of lysosomal 
enzymes, wortmannin has been reported to inhibit  some 
protein kinases, such as myosin light chain kinase (Naka- 
nishi et al., 1993), and PI 4-kinase (Cheatham et al., 1994). 
However, our results are strengthened  by finding that an 
unrelated PI 3-kinase inhibitor, LY294002,  also alters the 
distribution  of M6PRs  and  the  morphology of the  PLC, 
but has little effect on a variety of protein kinases (Vlahos 
et al., 1994).  We also found that staurosporine, a  general 
The Journal of Cell Biology, Volume 130, 1995  790 Figure 9.  M6PRs become depleted from the swollen PLC vacuoles during wortmannin treatment: immunoperoxidase observations at 
the electron microscopic level. (A) In control cells, M6PRs are located in tubular elements of the TGN, clathrin-coated buds and vesi- 
cles, and in larger vesicles of the PLC. (B and C) After treatment with 1 IxM wortmarmin for 15 min, large dilated vacuoles (V) of the 
PLC form which contain significant amounts of immunoperoxidase reaction product. (D-F) After treatment with 1 ~M wortmannin  for 
3 h, large dilated vacuoles (V) are still found in the Golgi region, however, these vacuoles have very little reaction product. Conversely, 
tubular elements of the TGN still contain detectable levels of M6PRs. Bars, 0.5 Ixm. 
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which blocks early steps in Golgi transport (Davidson et 
al., 1992), had no observable effect on the sorting of cathep- 
sin D from the TGN and subsequent processing in the PLC/ 
late endosome compartments. Similarly, it seems unlikely 
that  wortmannin  exerts its  effects on lysosomal enzyme 
trafficking through PI 4-kinase because concentrations as 
low as 100 nM wortmannin, which have little effect on PI 
4-kinase (Stephens et al., 1994b), resulted in ~40% of newly 
synthesized cathepsin D  being missorted to the secretory 
pathway. Finally, in the accompanying manuscript, David- 
son has independently found that wortmannin inhibits ly- 
sosomal enzyme sorting, and furthermore, he reports that 
the concentration of wortmannin required to inhibit lyso- 
somal enzyme delivery varies considerably between differ- 
ent cell types, but can be in the 20--40 nm range (Davidson, 
1995).  The reasons for differences in sensitivity could be 
related to the presence of multiple PI 3-kinases or differ- 
ential  metabolism  of  the  drug  in  different  cells.  Thus, 
while a  small role for PI 4-kinase cannot be completely 
ruled out, our studies and those of Davidson are most con- 
sistent with wortmannin inhibiting a PI 3-kinase that is in- 
volved in the trafficking of newly synthesized lysosomal 
enzymes. Davidson's studies further complement ours by 
showing that wortmannin does not inhibit the formation of 
M6P residues nor the M6P-dependent uptake of lysosomal 
enzymes by cell surface M6PRs (Davidson, 1995). 
Which of the PI 3-kinase isoforms might be involved in 
lysosomal enzyme trafficking? One possibility is the p110/ 
p85  PI  3-kinase  that  has  already been  shown  to  be  in- 
volved in the endocytosis and trafficking of the PDGF re- 
ceptor (Joly et al., 1994). However, we consider this un- 
likely  given  that  this  enzyme is  exquisitely sensitive  to 
Figure I0.  Wortmannin does 
not affect the TGN  or lyso- 
somes.  Cells  were  treated 
with 1 txM wortmannin for 15 
min  at  37°C  and  then  fixed 
and stained by double-immu- 
no  fluorescence  with  anti- 
TGN38  and 10E6  antibodies 
or anti-cathepsin D (CD) and 
10E6 antibodies as indicated 
on the micrographs. 
inhibition by wortmannin (IC50 =  1-5 nM). The differen- 
tial sensitivity of distinct membrane trafficking pathways 
in mammalian cells to wortmannin is intriguing in light 
of  recent  studies  demonstrating  that  yeast  Vps34p  PI 
3-kinase activity is also less sensitive to wortmannin (IC50 
N4  IxM) (Stack and Emr, 1994). Recently, a  Ptdlns-spe- 
cific 3-kinase was  discovered in bovine adrenoreticulosa 
cells that exhibits sensitivity to wortmannin (Stephens et 
al.,  1994b) similar to that observed for Vps34 PI 3-kinase 
(Stack and Emr, 1994), and to the level required to block 
lysosomal enzyme sorting. Therefore, it is possible that the 
enzyme discovered by Stephens et al.,  (1994b) may be a 
VPS34 homolog, or it is also possible that yet another PI 
3-kinase awaits discovery. 
Several experiments suggest that wortmannin is acting 
at the level of the TGN to inhibit proper sorting of lysoso- 
mal enzymes from the constitutive secretory pathway. The 
conclusions from these data are summarized in  a  model 
presented in Fig. 13. First, we found that when newly syn- 
thesized  cathepsin  D  was  allowed  to  accumulate  in  the 
TGN at 20°C,  a  15-min incubation with wortmannin was 
sufficient  to  quantitatively  missort  cathepsin  D  to  the 
secretory pathway following shift to 37°C.  This rapid ac- 
tion of wortmannin is faster by a factor of 3-4 fold than the 
apparent time it takes lysosomal enzymes to get from the 
TGN to the PLC (Rosenfeld et al., 1982; Rijnboutt et al., 
1992), and is therefore not compatible with an effect on 
the M6P-dependent delivery site at the PLC. 
Second, in addition to inhibiting lysosomal enzyme sort- 
ing and delivery, both wortmannin and LY294002 altered 
the distribution of the M6PR. Within 15 rain after addition 
of the inhibitors, M6PR-enriched vesicles of the PLC/late 
endosome compartment were found to be significantly di- 
The Journal of Cell Biology, Volume 130, 1995  792 Figure 11.  Anti-M6PR antibodies bind to the cells  surface and 
are delivered by endocytosis to the LY294002-induced vacuoles. 
Control cells (A) or cells preincubated with 70 p,M LY294002 for 
3 h (B), followed by incubation with anti-M6PR IgG for 30 min at 
37°C. Cells  were then fixed,  permeabilized,  and incubated with 
rhodamine-conjugated anti-rabbit antibodies to detect the inter- 
nalized anti-M6PR antibodies. 
lated.  Gradually, however, these same dilated PLC vacu- 
oles stained  less intensely for M6PRs such that by 3  h  of 
treatment, the vacuoles contained almost no detectable re- 
ceptors. Instead, receptors were abundant in the TGN. In 
the case of LY294002, this redistribution was reversible. In 
addition to these changes, the level of cell surface M6PRs 
decreased approximately fourfold over the same time pe- 
riod.  Because  cell  surface M6PRs  were capable  of being 
endocytosed and delivered to the PLC in the presence of 
wortmannin, inhibition of receptor delivery to the cell sur- 
face must have occurred. The simplest  explanation  to ac- 
count for all these results is that wortmannin inhibits for- 
ward movement out of the TGN, but does not effect the 
recycling of M6PRs from the cell suface or the PLC back 
to the TGN (Fig. 13). 
Although wortmannin  had  a  profound effect on trans- 
port of M6PRs from the TGN to the PLC, we and David- 
son (Davidson, 1995) independently found that wortman- 
nin had no apparent effect on the endocytic trafficking of 
M6PRs  indicating  that  PI  3-kinases  are  not  involved  in 
these  M6PR  trafficking  events.  However,  others  have 
found that the endocytic trafficking of mutant PDGF and 
CSF  receptors  lacking  the  p85/pl10  PI 3-kinase-binding 
sites  is significantly impaired.  Thus, it would appear that 
regulation  of the endocytic trafficking of tyrosine kinase- 
type  receptors  (PDGF,  CSF)  and  the  M6PR  differs 
greatly. 
Apart from its  effect on lysosomal enzyme and M6PR 
trafficking, we also found that wortmannin (and LY294002) 
induced  a  very  specific  swelling  of PLC/late  endosome 
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Figure 12.  LY294002 treatment causes a  reduction in cell surface 
M6PRs.  Cells were  incubated  in the presence  or  absence  of 70 
~M LY294002 for various periods of time (as indicated below the 
graph) at 37°C. In another case, cells were incubated in the pres- 
ence of LY294002 as above for 3 h, cells were then washed exten- 
sively with MEM containing 10% CSS and incubated in the same 
for 2 h  (120' recovery on the graph). At the end of all incuba- 
tions,  cells were fixed and incubated with anti-M6PR IgG to de- 
tect cell surface receptors. Goat anti-rabbit IgG conjugated with 
alkaline phosphatase was used to generate  a colorimetry assay 
for surface receptors. Each time point represents the average of 
triplicate samples and the results are expressed as the percentage 
of control (untreated) values. 
vesicles  within  15  min  (Fig.  13).  The  acidotropic  weak 
bases  NHaC1 and  chloroquine  produce  a  similar  but  less 
organelle-specific swelling (Brown et al.,  1984, 1986), and 
in  addition,  also  cause  the  missorting  of  lysosomal  en- 
zymes because neutralization of the PLC delivery site pre- 
vents  receptor-ligand  dissociation  (Gonzalez-Noreiga  et 
al.,  1980).  However,  the  swelling  of the  PLC/late  endo- 
some  vesicles  by wortmannin  was  not  consistent  with  a 
simple  weak  base-neutralization  effect,  and  also  did  not 
appear to be directly coupled to changes in M6PR distri- 
bution nor to the missorting of lysosomal enzymes. First, 
we found that  accumulation of the pH-sensitive  vital dye 
acridine  orange into the wortmannin-induced  PLC vacu- 
oles was apparently unaltered indicating that the pH of the 
PLC was not significantly changed.  Second, wortmannin 
rapidly (within 15 min) caused the missorting of cathepsin 
D  that  had  previously  accumulated  in  the  TGN  by  the 
20°C  block.  And  third,  in  the  presence  of weak  bases, 
swollen PLC vacuoles remain  heavily stained  for M6PRs 
(Brown et al.,  1984, 1986; Geuze et al.,  1985), whereas  in 
wortmannin (or LY294002), PLC vacuoles became revers- 
ibly (in the case of LY294002) depleted of receptors which 
were instead easily detected in the TGN. It is curious that 
the swelling of the PLC occurred so rapidly and that de- 
pletion of receptors took longer. The "apparent" slow de- 
pletion of receptors over a 3-h period is likely due in part 
to the  nonquantitive  nature  of immunofluorescence,  but 
also to the time it takes the entire pool of receptors to re- 
cycle back to the TGN (Brown et al., 1986). Although the 
swelling of the PLC does not appear to inhibit M6PR recy- 
cling back to the TGN, we cannot rule out the possibility 
that wortmannin inhibits an activity in the PLC that is re- 
quired  to "reactivate"  M6PRs,  so that in the presence  of 
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Figure 13.  Summary of the effect of PI 3-kinase inhibitors, wort- 
mannin and LY294002,  on lysosomal enzyme and M6PR traffick- 
ing. (A) In untreated cells, M6PRs (O) transport newly synthe- 
sized lysosomal enzymes (T) from the TGN to the PLC where 
the enzymes dissociate from the receptors for ultimate delivery 
to lysosomes. M6PRs can recycle back to the TGN or they can 
continue on to the plasma membrane (PM) to engage in recep- 
tor-mediated endocytosis to early endosomes (EE). (B) In cells 
treated with wortmannin or LY294002,  our results are most con- 
sistent with a model in which sorting of M6PR-enzymes from the 
TGN for delivery to the PLC is inhibited resulting in the secre- 
tion of newly synthesized lysosomal enzymes. In addition, vesi- 
cles of the PLC become swollen, however, it is unclear if this 
morphological change is related in any way to the missorting that 
most likely occurs in the TGN. Question marks are placed at sev- 
eral steps to indicate that (a) the extent to which wortmannin af- 
fects forward movement out of the PLC is unknown, and (b) the 
endocytic trafficking of receptors may be subjected to different 
levels of PI 3-kinase regulation. The symbols for M6PRs are not 
meant to accurately represent the proportion of receptors in each 
compartment but only to schematically demonstrate changes that 
occur after treatment with PI 3-kinase inhibitors, and not all pos- 
sible M6PR pathways are shown. 
wortmannin, M6PRs reach the PLC, dissociate their ligands, 
but return to the TGN in a nonfunctional form. 
Taken together, both the biochemical studies of cathep- 
sin  D  trafficking and  the  immunocytochemical  observa- 
tions of the M6PR are most consistent with the PI 3-kinase 
inhibitors  affecting  sorting  of lysosomal enzymes  within 
the TGN  and not downstream  at the delivery site in the 
PLC.  Apparently,  in  the  presence  of wortmannin,  both 
ligand (cathepsin D) and receptor are located together in 
the TGN, however, they are unable to productively inter- 
act to induce sorting. How any particular PI 3-kinase could 
influence the sorting, packaging, and delivery of vesicular 
cargo is unclear. In the case of lysosomal enzyme and vac- 
uolar protein trafficking, phosphorylated forms  of phos- 
phatidylinositol generated  by a  PI  3-kinase,  could influ- 
ence receptor-mediated transport in several ways. For ex- 
ample, PI 3-kinase and/or its products could promote the 
deformation of membrane  into vesicle buds  (Sheetz  and 
Singer, 1974) or the formation of clathrin-coated vesicles. 
Our preliminary studies suggest that wortmannin does not 
inhibit the  formation  of AP-1  type  clathrin-coated buds 
and vesicles on TGN membranes  (Fasano, M.  and W. J. 
Brown, unpublished data). Alternatively, accumulation of 
PI(3)P  in  the  membrane  could  influence  the  ability of 
M6PRs to bind ligand or become productively localized to 
clathrin-coated buds in the TGN. 
In  conclusion,  we  have  provided  evidence  that  a  PI 
3-kinase is involved in the sorting and delivery of newly 
synthesized lysosomal enzymes in mammalian cells. These 
studies provide the first evidence for a molecular link be- 
tween  the  regulation  of  intracellular  trafficking  to  the 
mammalian  lysosome and  the  yeast vacuole.  We  expect 
that  in  addition to  identifying a  VPS34  homolog,  other 
mammalian homologs to  VPS genes will be identified in 
the near future, for example, the VPS15 encoded protein 
kinase that regulates the activity of Vps34 PI 3-kinase. 
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